Merck, Bristol Myers and Pfizer...which one is most attractive? #AskHalftime
The "Halftime Report" traders answer viewer questions in #AskHalftime. Subscribe to CNBC Pro to access full episodes of Halftime Report: https://cnb.cx/2PAd42N
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Merck, Bristol Myers and Pfizer...which one is most attractive? #AskHalftime канала CNBC Television
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Merck, Bristol Myers and Pfizer...which one is most attractive? #AskHalftime канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Levi Strauss shares fall on mixed Q2 results](https://i.ytimg.com/vi/pPYntT13Q_g/default.jpg)
![Nike stock trips on earnings after missing revenue estimates](https://i.ytimg.com/vi/a-d1J6QNDoQ/default.jpg)
![Opening Bell, November 4, 2022](https://i.ytimg.com/vi/JMXpeyy-Zc4/default.jpg)
![Calls of the Day: Rio Tinto, AT&T, Coca-Cola & Disney](https://i.ytimg.com/vi/MVh13ZK3Ldk/default.jpg)
![RBC Brewin Dolphin: Overweight in U.S. stocks and tech](https://i.ytimg.com/vi/7h-7m4mWLuI/default.jpg)
![Breaking down shares of Hilton, Expedia and Match Group](https://i.ytimg.com/vi/MPrkSqnures/default.jpg)
![Second half of 2024 could be more volatile, says Kari Firestone](https://i.ytimg.com/vi/9iVGXprA6pA/default.jpg)
![Cramer's Mad Dash: US Bancorp](https://i.ytimg.com/vi/9lLPfdqMlfM/default.jpg)
![Eli Lilly and Novo Nordisk are ahead in manufacturing but need time to meet demand, says Louise Chen](https://i.ytimg.com/vi/vy70w7YfHiY/default.jpg)
![Lockheed Martin sees record order volume in 2022 as earnings beat estimates](https://i.ytimg.com/vi/FAUB_hVp2uo/default.jpg)
![Peter Thiel backs Donald Trump over Joe Biden](https://i.ytimg.com/vi/WT0LZYlV6aA/default.jpg)
![Ferguson: A positive PCE report could be meaningful for the FOMC this time around](https://i.ytimg.com/vi/QjZ7MUNcI1U/default.jpg)
![Fordham: Market participants made up their minds a long time ago Trump was the best choice to win](https://i.ytimg.com/vi/H2OBbazg364/default.jpg)
![Cramer's Stop Trading: Dutch Bros](https://i.ytimg.com/vi/7H89UkI3YdM/default.jpg)
![Nagel: This is likely the last bad report for Nike, a clearing event](https://i.ytimg.com/vi/OcWgQhOxSGI/default.jpg)
![Biden’s debate performance worries Democrats](https://i.ytimg.com/vi/xuRg1zodZBo/default.jpg)
![Stick with momentum winners in this market, says Raymond James' Matt Orton](https://i.ytimg.com/vi/9LJpoEMTAvM/default.jpg)
![Clean Start: This clean-tech startup transforms carbon emissions into vodka](https://i.ytimg.com/vi/nQdg79pWeNA/default.jpg)
![Opening Bell: June 27, 2024](https://i.ytimg.com/vi/n198r731Z90/default.jpg)
![GE Vernova CEO Scott Strazik: We can meet energy demands of AI](https://i.ytimg.com/vi/7JN91RTOj9g/default.jpg)
![Catalyst for small caps will be earnings growth, says Essex Investment's Nancy Prial](https://i.ytimg.com/vi/Mwl0mOibVz0/default.jpg)